The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127624961 12762496 1 I 20160914 20160920 20160920 PER US-PFIZER INC-2016434375 PFIZER 0.00 M Y 0.00000 20160920 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127624961 12762496 1 PS NEURONTIN GABAPENTIN 1 900 MG, 3X/DAY (3X300MG TID, 2700 MG/DAY) U 20882 900 MG FILM-COATED TABLET TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127624961 12762496 1 Diabetic neuropathy

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
127624961 12762496 Herpes zoster
127624961 12762496 Product use issue
127624961 12762496 Pyrexia
127624961 12762496 Tremor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found